The present review defines the specific role of different assays along with imaging modalities that could help in the clinical management of a patient across AA and CA men whom the clinician deems to be suspicious of harboring undiagnosed prostate cancer, specifically focusing on those patients with an elevated serum PSA. This evidence concerns the gene KLK3 and prostate carcinoma.